Kappa opioid receptor tolerance in the guinea pig hippocampus

Journal of Pharmacology and Experimental Therapeutics

Volumn 281, Issue 1, 1997, Pages 123-128

  Jin, Wenzhen ^a   Terman, Gregory W ^b   Chavkin, Charles ^a,b  

^a UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF WASHINGTON   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

3,4 DICHLORO N METHYL N [2 (1 PYRROLIDINYL)CYCLOHEXYL]BENZENEACETAMIDE METHANESULFONATE; DIZOCILPINE; DYNORPHIN; ENKEPHALIN[2 DEXTRO ALANINE 4 METHYLPHENYLALANINE 5 GLYCINE]; KAPPA OPIATE RECEPTOR; KAPPA OPIATE RECEPTOR AGONIST; MU OPIATE RECEPTOR AGONIST; N METHYL DEXTRO ASPARTIC ACID RECEPTOR; N METHYL DEXTRO ASPARTIC ACID RECEPTOR BLOCKING AGENT; N METHYL N [7 (1 PYRROLIDINYL) 1 OXASPIRO[4.5]DEC 8 YL]BENZENEACETAMIDE; NORBINALTORPHIMINE; OPIATE;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG TOLERANCE; GUINEA PIG; HIPPOCAMPUS; HYPOTHERMIA; MALE; NONHUMAN; PRIORITY JOURNAL; SUBCUTANEOUS DRUG ADMINISTRATION;

3,4-DICHLORO-N-METHYL-N-(2-(1-PYRROLIDINYL)-CYCLOHEXYL)-BENZENEACETAMIDE, (TRANS)-ISOMER; ANIMALS; BENZENEACETAMIDES; DIZOCILPINE MALEATE; DRUG TOLERANCE; GUINEA PIGS; HIPPOCAMPUS; MALE; PYRROLIDINES; RECEPTORS, N-METHYL-D-ASPARTATE; RECEPTORS, OPIOID, KAPPA; RECEPTORS, OPIOID, MU;

EID: 0030999677     PISSN: 00223565     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (42)

1. BEN, E. S., MAREK, P., VACCTARTNO, A. L., MOGIL, J. S., STERNBERG, W. F. AND LIEBESKIND, J. C.: The NMDA receptor antagonist MK-801 prevents longlasting non-associative morphine tolerance in the rat. Brain Res, 575; 304-300, 1992.
2. BHARGAVA, H. N.: Diversity of agents that modify opioid tolerance, physical dependence, abstinence syndrome, and self-administrative behavior. Pharmacol. Rev. 46: 293-324, 1994.
3. BHARGAVA, H. N., GULATI, A. AND RAMARAO, P.: Effect of chronic administration of U-50.488H on tolerance to its pharmacological actions and on multiple opioid receptors in rat brain regions and spinal cord, J. Pharmacol. Exp. Ther. 251: 121-26, 1989a.
4. BHARGAVA, H. N., MATWYSHYN, G. A. AND GUDEHITHLU, K. P.: Effects of acute and chronic administration of dizocilpine on the pharmacological responses to U-50, 488H and brain and spinal cord kappa-opioid receptors in the rat. Pharmacology 51: 323-330, 1995.
5. BHARGAVA, H. N., MATWYSHYN, G. A., RATTAN, A. K., Koo, K. L. AND TKJWANI, G. A.: The effect of U-50.488H tolerance-dependence and abstinence on the levels of dynorphin (1-13) in brain regions, spinal cord, pituitary gland and peripheral tissues of the rat. Brain Res. 600: 151-155, 1993.
6. BHARGAVA, H. N., MATWYSHYN, G. A., RATTAN, A. K., Koo, K. L. AND TEJWANI, G. A.; beta-Endorphin-like immunoreactivity in discrete brain regions, spinal cord, pituitary gland and peripheral tissues of U-50.488H-tolerant and -abstinent rats. J. Pharmacol. Exp. Ther. 268: 856-861, 1994.
7. BHARGAVA, H. N., RAMARAO, P. AND GULATI, A.; Effects of morphine in rats treated chronically with U-50.488 H. a kappa opioid receptor agonist. Eur. J. Pharmacol. 162: 257-264, 1989b.
8. BHAKUAVA, H. N. AND THURAT, S. N.; Effect of dizocilpine (MK-801) on analgesia and tolerance induced by U-50.488H, a kappa-opioid receptor agonist, in the mouse. Brain Res. 649: 111-116, 1994.
9. BHARGAVA, H. N.: Non-competitive antagonism of N-Methyl-D-Aaspartate receptor inhibits tolerance to the analgesic action of U-50.48SH, a kappaopiate receptor agonist in the rat. Gen. Pharmacol, 26: 1055-1060, 1995.
10. BIANCHI, G.: High-performance liquid Chromatographie assay of kappa opioid selective benzeneaeetamide derivatives (U50.488, U69.593 and PD117302) in rat plasma and brain. J. Chromatogr, 491: 481-487, 1989.
11. CHAVKIN, C. AND GOLDSTEIN, A.; Opioid receptor reserve in normal and morphine-tolerant guinea pig ileum myenteric plexus. Proc. Natl. Acad. Sci. U.S.A. 81: 7253-7257, 1984.
12. COWAN, A. AND MURRAY, C. W.: Effect of nor-binaltorphimirte on the behavior of mice and rats receiving multiple injections of U-50.488. Prog. Clin. Biol. Res. 328:303-306, 1990.
13. COX, B. M. AND CHAVKIN, C.: Comparison of dynorphin-selective Kappa receptors in mouse vas deferens and guinea pig ileum. Spare receptor fraction as a determinant of potency, Mol. Pharmacol. 23: 36-43, 1983.
14. DECKER, M. W. AND MCGAUGH, J. L.; The role of interactions between the cholinerpic system and other neuromodulatory systems in learning and memory. Synapse 7: 151-108, 1991.
15. ELLIOTT, K., MINAMI, N., KOLESNIKDV, Y. A., PASTERNAK, G. W., INTURRISI, C. E.: The NMDA receptor antagonist, LY274614 and MK-801. and the nitric oxide synthetase inhibitor. NG-nitro-L-arginine. attenuate analgesic tolerance to the mu-opioid morphine but not to kappa opioids. Pain 56: 69-75, 1995.
16. FANTOZZI, R., MULLIKIN, K. D. AND BLUME, A. J.: Irreversible inactivation of the opiate receptors in the neuroblastoma x glioma hybrid NG108-15 by chlor- naltrexamine, Mol, Pharmacol. 20: 8-15, 1981.
17. GOLPSTEIN, A. AND Sninz, R.: Morphine-tolerant longitudinal muscle strip from guinea-pig ileum. Br. J. Pharmacol. 48: 655-666, 1973.
18. GULATI, A. AND BHARGAVA, H. N.: Upregulation of brain and spinal cord kappa opioid receptors in morphine tolerant dependent mice. FASEB. J. 2: A368, 1988.
19. Ho, B. Y. AND TAKEMORI, A. E.: Serotonergic involvement in the antinocicvptive action of and the development of tolerance to the kappa-opioid receptor agonist, U-50. 488H. J. Pharmacol. Exp. Ther. 250: 508-514, 1989.
20. JIANG, H. K., OWYANG, V. V., HONG, J. S. AND GALLAGHER, M.: Elevated dynorphin in the hippocampal formation of aged rats: relation to cognitive impairment on a spatial learning task. Proc. Natl. Acad. Sci, U.S.A. 86: 2948-2951, 1989.
21. KENNEDY, C. AND HENDERSON, G.: μ-opioid receptor inhibition of calcium current: development of homologous tolerance in single SH-SY5Y cells following chronic exposure to morphine in vitro. Mol. Pharmacol. 40:1000-1005.1991
22. KOLKSNIKOV, Y. A., PERKANY, J. AND PASTERNAK. G. W.: Blockade of mu and kappa 1 opioid analgesic tolerance by NPC17742, a novel NMDA antagonist Life Sci. 53: 1489-1494, 1993.
23. MAO, J., PRICE, D. D. AND MAYER, D. J.: The mechanisms of hyperalgesia and morphine tolerance: a current view of their possible interactions. Pain 62: 259-274, 1995.
24. MAREK, P., BEN, E. S., GOLD, M. AND LIEBESKIND, J. C.: Excitatory aminu acid antagonists (kynurenic acid and MK-801) attenuate the development of morphine tolerance in the rat. Brain Res. 547: 77-81, 1991.
25. Me LEAN, S., ROTIIMAN, R. B., JACOBSON, A. E., RICE, D. C. AND HERKENHAM, M.: Distribution of opiate receptor subtypes and enkephalin and dynorphin immunoreactivity in the hippocampus of squirrel, guinea pig, rat, and hamster, J. Comp, Neurol. 255: 497-510, 1987.
26. MILAN'ES, M. V., GONZALEZ, M. L., FUENTE, T. AND VARGAS, M. L.; Pituitary. adrenocortical response to acute and chronic administration of U-50.488H in the rat. Neuropeptidea 20: 95-102, 1991.
27. SIMMONS, M. L. AND CHAVKIN, C.: Endogenous opioid regulation of hippocampal function. In International Review of Neurobiology. ed. by R. J. Bradley, A. R. Harris and P. Jenner, vol. 39, pp. 146-197, Academic Press, San Diego. CA. 1996.
28. 1 opioid receptors in the guinea pig dentate gyrus. J. Neurophysiol. 72: 1697-1705, 1994.
29. SOFUOGLU., M., PORTOGHKSE, P. S. AND TAKEMORI, A. E.: Maintenance of acute morphine tolerance in mice by selective blockage of kappa opioid receptors with norbinaltorphimine. Eur. J. Pharmacol. 210: 159-162, 1992.
30. TAKAHANHI, M., SENND, T. AND KANETO, H.: Role of spinal kappa opioid receptors in the blockade of the development of antinociceptive tolerance to morphine, Eur. J. Pharmacol. 200: 293-297, 1991.
31. TANGANELLI, S., ANTONELLI, T., MORARI, M., BIANCHI, C. AND BEANI, L.: Glutamate antagonists prevent morphine withdrawal in mice and gyinea pigs. Neuro- sci. Lett, 122:270-272, 1991.
32. TERMAN, G. W., WAONER, J. J. AND CHAVKIN, C.: Kappa opioids inhibit induction of long-term potentiation in the dentate gyrus of the guinea pig hipputsmpus. J. Neurosci. 14: 4740-4747, 1994.
33. THORAT, S. N., VEERANNA, REDDY, P. L. AND BHARGAVA, H. N.: Biochemical and behavioral studies on the interaction between mu- and kappa-opiate agonuts in mice. Brain Res, 615: 191-198, 1993.
34. TORTELLA, F. C., ECHEVARRIA, E., LIPKOWSKJ, A. W., TAKEMOKI, A. E., PORTOGHESE, P. S. AND HULADAY, J. W.: Selective kappa antagonist properties of norbinaltorphimine in the rat MES seizure model. Life Sci. 44: 661-665, 1989
35. TORTELLA, F. C., ROBLES, L., ECHEVARRIA, E., HUNTER, J. C. AND HUGHES, J.: PD11732, a selective non-peptide opioid kappa agonist, protects against NMDA and maximal electroshock convulsions in rats. Life Sci. 46: 7, 1990
36. TRUJILLO K. A. AND AKIL, H.: Inhibition of morphine tolerance and dependence by the NMDA receptor antagonist MK-801, Science 251; 85-88, 1991.
37. VONVOIGTLANDER, P. F., LEWIS, R. A. AND NEFF, G. L.: Kappa opioid analgesias dependent on serotonergic mechanisms. J. Pharmacol. Exp. Ther. 231; 270-274, 1984.
38. WAGNER, J., TERMAN, G. AND CHAVKIN, C.: Endogenous dynorphins inhibit excitatory neurotransmission and block LTP induction in the hippocampus. Nature 363: 451-454, 1993.
39. WAGNER, J. J., CAUDLE, R. M., NEUMAIER, J. F. AND CHAVKIN, C.: Stimulation of endogenous opioid release displaces mu receptor binding in rat hippocampus. Neuroscience 37: 45-53, 1990.
40. 1-opioid receptors in guinea pig hippocampus. J. Neurochem, 57: 333-343, 1991.
41. WALKER, M. J., LE, A. D., POULOS, C. X. AND CAPPELL, H.: Chronic selective blockade of mu opioid receptors produces analgesia and augmentation of the effects of a kappa agonist. Brain Res. 538: 181-186, 1991.
42. WIMPEY, T. L., OPHEIM, K. E. AND CHAVKIN, C.: Effects of chronic morphine administration on the Mu and Delta opioid responses in the CA1 region of the rat hippocampus. J. Pharmacol, Exp. Ther. 251: 406-411, 1989.